Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 6, Issue 4, 2024

Professor Kuang Shixiang Treatment of Myasthenia Gravis Two Cases

Download as PDF

DOI: 10.23977/medcm.2024.060425 | Downloads: 14 | Views: 379

Author(s)

Mingjie Yu 1, Shixiang Kuang 2

Affiliation(s)

1 Guizhou University of Traditional Chinese Medicine, Guiyang, China
2 The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China

Corresponding Author

Shixiang Kuang

ABSTRACT

Myasthenia gravis (MG) is one of the internationally recognized refractory neurological diseases, and there is no ideal treatment so far. Western medicine treatment is based on symptomatic treatment to relieve symptoms. In terms of effect, western medicine treatment takes effect quickly and pays more attention to the realization of short-term goals. In the treatment of traditional Chinese medicine, more attention is paid to "holistic concept and dialectical treatment", which is dominated by regulating the function of zang-fu organs and promoting the functional recovery of the body. Compared with western medicine, traditional Chinese medicine has a slow onset, but because of its uniqueness, once it is effective, it can make the disease not easy to relapse. From the long-term goal, it highlights the importance of traditional Chinese medicine. Professor Kuang Shixiang has been committed to the use of traditional Chinese medicine in the treatment of MG in the past 20 years, advocating the combination of traditional Chinese and Western medicine, and has accumulated rich clinical experience. Professor Kuang Shixiang attaches great importance to the therapeutic principles of tonifying spleen and kidney, warming yang and removing dampness, removing blood stasis and detoxification, which provides an effective idea and method for the treatment of MG with traditional Chinese medicine.

KEYWORDS

Myasthenia gravis, etiology and pathogenesis, experience of Chinese medicine

CITE THIS PAPER

Mingjie Yu, Shixiang Kuang, Professor Kuang Shixiang Treatment of Myasthenia Gravis Two Cases. MEDS Chinese Medicine (2024) Vol. 6: 187-192. DOI: http://dx.doi.org/10.23977/medcm.2024.060425.

REFERENCES

[1] Somnier FE, Engel PJ. The occurrence of anti-titin antibodies and thymomas: a population survey of MG 1970-1999. Neurology. 2002 Jul 9; 59(1):92-98.
[2] Bettini M, Chaves M, Cristiano E, Pagotto V, Perez L, Giunta D, Rugiero M. Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina. Neuroepidemiology. 2017; 48(3-4):119-123. 
[3] Fang W, Li Y, Mo R, Wang J, Qiu L, Ou C, Lin Z, Huang Z, Feng H, He X, Wang W, Xu P, Wang L, Ran H, Liu W. Hospital and healthcare insurance system record-based epidemiological study of myasthenia gravis in southern and northern China. Neurol Sci. 2020 May; 41(5):1211-1223.
[4] Gelinas D, Parvin-Nejad S, Phillips G, Cole C, Hughes T, Silvestri N, Govindarajan R, Jefferson M, Campbell J, Burnett H. The humanistic burden of myasthenia gravis: A systematic literature review. J Neurol Sci. 2022 Jun 15; 437:120268.
[5] Waters MJ, Field D, Ravindran J. Refractory myasthenia gravis successfully treated with ofatumumab. Muscle Nerve. 2019 Dec; 60(6):E45-E47. 
[6] Huiyong Zhang, Weifeng Xie, Jingsheng Zhang. Textual research on TCM terms related to common clinical manifestations of myasthenia gravis in ancient literature [J].Liaoning Journal of Traditional Chinese Medicine, 2022,49 (01): 15-19.
[7] Chenkai Huang. Study on the correlation between serum antibodies and TCM syndromes in patients with myasthenia gravis [D].Chengdu University of Traditional Chinese Medicine, 2019.
[8] Yi Chen, Xuhong Jiang, Yangyang Ding, et al. Professor Qiu Changlin's TCM experience in the treatment of myasthenia gravis crisis [J].Journal of Zhejiang University of Traditional Chinese Medicine, 2022,46 (05): 522-526.
[9] Xianwen Zhang, Shixiang Kuang, Wang Xing'an Li. Professor Kuang Shixiang's experience in the diagnosis and treatment of myasthenia gravis [J].Clinical research of traditional Chinese medicine, 2013,5 (07): 10-11.
[10] Shixiang Kuang, Yaojun Kuang. Four stages of immune regulation of myasthenia gravis [J].Chinese medicine emergency, 2024, 33 (01): 62-65.
[11] Shixiang Kuang, Zhilan Zhao, Yan Li, et al. Five binding points of integrated traditional Chinese and Western medicine in the prevention and treatment of myasthenia gravis [J].Journal of Guizhou University of Traditional Chinese Medicine, 2024,46 (02): 45-48.
[12] Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016 Aug; 263(8):1473-1494. 
[13] Junnan Wang, Yongfeng Zhou, Yuanyuan Cui, et al. Research progress on the material basis and mechanism of licorice in enhancing immunity [J]. Chinese herbal medicine, 2021, 52 (06): 1844-1850.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 8494
Visits: 470923

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.